Polynom Investment

Polynom AB is a venture capital firm based in Malmö, Sweden, founded in 2017. The company focuses on investing in scaleups and startups across Sweden and Europe, aiming to support small savers and contribute positively to society. With a rolling investment horizon of 10 years, Polynom targets a return of 15% on its investments. By concentrating on growing businesses, Polynom seeks to foster innovation and economic development in the regions it serves.

Mats Lind

CEO

1 past transactions

PharmNovo

Venture Round in 2022
PharmNovo AB is a Swedish biopharmaceutical company based in Lund, established in 2008. It specializes in the development of therapeutic drugs aimed at treating neuro diseases, particularly hyper excitability disorders such as chronic pain. The company's leading product, PN6047, is designed to alleviate chronic pain and address issues of hypersensitivity. PharmNovo employs a research approach that integrates advanced chemistry and bioscience to create safe, effective, and non-addictive opioid alternatives for managing nervous system disorders. By focusing on neuroscience and translational medicine, PharmNovo aims to enhance the quality of life for individuals suffering from chronic pain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.